They're now on Clinicialtrials.gov:
To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID (BLOC)
They say they started on June 16. They're recruiting in 4 locations: 2 in Berlin (including Charité), 1 in Cologne, and 1 in Munster, and one in Cologne.